1 min read

Unlocking the potential of your gene and cell therapy with Pfizer’s gene-ious approach

1 min read

From complex manufacturing processes to stringent regulatory requirements, your gene and cell therapy faces a variety of challenges on the journey to the patients waiting.

In this webinar with Outsourced Pharma, Shanker Iyer, our Business Development Lead for Cell and Gene Therapy, shares his valuable insights into how we can help you overcome these challenges and take your therapy to market.

You’ll also learn about:

  • Deep technical expertise: Our global team of 70+ experienced scientists support your therapeutic project, bringing scalable viral vector development and manufacturing capabilities from start to finish.
  • Commitment to quality: Discover how Pfizer’s Integrated Manufacturing Excellence (IMEX) system helps ensure the reliability and quality of your gene and cell therapy project.
  • Project prioritization and confidentiality: Learn about the robust processes we put in place to prioritize patient impact and maintain strict confidentiality for your therapy.

 

To access the webinar, complete the form below

Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please tick the box below.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.